This study is being done to determine if treatment with metformin, a drug widely used for the
treatment of diabetes type 2, is safe and well tolerated by individuals with Autosomal
Dominant Polycystic Kidney Disease (ADPKD) who are not diabetic and who have slightly
decreased kidney function. The study will also evaluate the effects of metformin on kidney
growth and kidney function.